跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
LUNESTA - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
LUNESTA
Authorized
STANDARD
LUNESTA
sumitomo pharma canada, inc.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
51a7e748a2f58319
Company
sumitomo pharma canada, inc.
Type
Standard
Approval Details
Approval Id
51a7e748a2f58319
Drug Approval Canada Name
LUNESTA
Product Name
LUNESTA
Status
Marketed
Status Date
2024-08-30
Original Market Date
2020-10-20
Din
02453207
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
28:24.92
Atc Original
N05CF04 ESZOPICLONE
Atc Name
n 05 cf 04
Aig Number
0157971001
Company Name
sumitomo pharma canada, inc.
Company Address
301, 7025 Langer Drive, Mississauga, Ontario, Canada, L5N 0E8
Active Ingredients
ESZOPICLONE
1 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
51a7e748a2f58319
Type
Standard
Back to Health Canada Approvals